S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
S&P 500   3,925.43 (+1.14%)
DOW   31,961.86 (+1.35%)
QQQ   324.13 (+0.82%)
AAPL   125.35 (-0.41%)
MSFT   234.55 (+0.55%)
FB   264.31 (-0.58%)
GOOGL   2,083.81 (+1.15%)
AMZN   3,159.53 (-1.09%)
TSLA   742.02 (+6.18%)
NVDA   579.96 (+2.52%)
BABA   250.34 (-0.95%)
CGC   35.60 (+0.82%)
GE   13.12 (+4.21%)
MU   92.52 (+4.86%)
NIO   51.86 (+5.60%)
AMD   86.94 (+2.60%)
T   29.38 (+0.69%)
F   12.27 (+5.59%)
ACB   11.64 (+3.84%)
DIS   197.51 (+0.21%)
BA   229.34 (+8.12%)
NFLX   553.41 (+1.33%)
BAC   36.38 (+2.42%)
Log in
ETR:GLJ

Grenke Competitors

€29.80
+0.02 (+0.07 %)
(As of 02/23/2021 12:00 AM ET)
Add
Compare
Today's Range
€29.80
Now: €29.80
€30.16
50-Day Range
€26.86
MA: €36.18
€43.10
52-Week Range
€23.92
Now: €29.80
€97.80
Volume182,899 shs
Average VolumeN/A
Market Capitalization$1.39 billion
P/E Ratio15.96
Dividend Yield2.61%
BetaN/A

Competitors

Grenke (ETR:GLJ) Vs. DWS, MLP, DBAN, ACKB, BME, and BKT

Should you be buying GLJ stock or one of its competitors? Companies in the industry of "asset management" are considered alternatives and competitors to Grenke, including DWS Group GmbH & Co. KGaA (DWS.F) (DWS), MLP (MLP), Deutsche Beteiligungs (DBAN), Ackermans & Van Haaren (ACKB), BlackRock Health Sciences Trust (BME), and BlackRock Income Trust (BKT).

Grenke (ETR:GLJ) and DWS Group GmbH & Co. KGaA (DWS.F) (ETR:DWS) are both financial services companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for Grenke and DWS Group GmbH & Co. KGaA (DWS.F), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grenke13402.38
DWS Group GmbH & Co. KGaA (DWS.F)021102.85

Grenke presently has a consensus target price of €65.75, suggesting a potential upside of 120.64%. DWS Group GmbH & Co. KGaA (DWS.F) has a consensus target price of €38.41, suggesting a potential upside of 11.15%. Given Grenke's higher possible upside, research analysts clearly believe Grenke is more favorable than DWS Group GmbH & Co. KGaA (DWS.F).

Profitability

This table compares Grenke and DWS Group GmbH & Co. KGaA (DWS.F)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrenkeN/AN/AN/A
DWS Group GmbH & Co. KGaA (DWS.F)N/AN/AN/A

Valuation & Earnings

This table compares Grenke and DWS Group GmbH & Co. KGaA (DWS.F)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grenke$537.48 million2.58$86.81 million€1.8715.96
DWS Group GmbH & Co. KGaA (DWS.F)$3.40 billion2.03$575 million€2.8812.02

DWS Group GmbH & Co. KGaA (DWS.F) has higher revenue and earnings than Grenke. DWS Group GmbH & Co. KGaA (DWS.F) is trading at a lower price-to-earnings ratio than Grenke, indicating that it is currently the more affordable of the two stocks.

Dividends

Grenke pays an annual dividend of €0.80 per share and has a dividend yield of 2.7%. DWS Group GmbH & Co. KGaA (DWS.F) pays an annual dividend of €1.81 per share and has a dividend yield of 5.2%. Grenke pays out 42.8% of its earnings in the form of a dividend. DWS Group GmbH & Co. KGaA (DWS.F) pays out 63.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

DWS Group GmbH & Co. KGaA (DWS.F) beats Grenke on 6 of the 10 factors compared between the two stocks.

Grenke (ETR:GLJ) and MLP (ETR:MLP) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.

Dividends

Grenke pays an annual dividend of €0.80 per share and has a dividend yield of 2.7%. MLP pays an annual dividend of €0.21 per share and has a dividend yield of 3.3%. Grenke pays out 42.8% of its earnings in the form of a dividend. MLP pays out 56.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Profitability

This table compares Grenke and MLP's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrenkeN/AN/AN/A
MLPN/AN/AN/A

Earnings and Valuation

This table compares Grenke and MLP's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grenke$537.48 million2.58$86.81 million€1.8715.96
MLP$735.06 million0.93$40.67 million€0.3716.85

Grenke has higher earnings, but lower revenue than MLP. Grenke is trading at a lower price-to-earnings ratio than MLP, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations for Grenke and MLP, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grenke13402.38
MLP00103.00

Grenke currently has a consensus price target of €65.75, suggesting a potential upside of 120.64%. MLP has a consensus price target of €7.70, suggesting a potential upside of 22.81%. Given Grenke's higher probable upside, equities research analysts plainly believe Grenke is more favorable than MLP.

Summary

Grenke beats MLP on 6 of the 10 factors compared between the two stocks.

Grenke (ETR:GLJ) and Deutsche Beteiligungs (ETR:DBAN) are both small-cap financial services companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.

Earnings and Valuation

This table compares Grenke and Deutsche Beteiligungs' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grenke$537.48 million2.58$86.81 million€1.8715.96
Deutsche Beteiligungs$39.80 million14.68$8.88 million€0.5965.85

Grenke has higher revenue and earnings than Deutsche Beteiligungs. Grenke is trading at a lower price-to-earnings ratio than Deutsche Beteiligungs, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Grenke and Deutsche Beteiligungs' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrenkeN/AN/AN/A
Deutsche BeteiligungsN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations for Grenke and Deutsche Beteiligungs, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grenke13402.38
Deutsche Beteiligungs00503.00

Grenke currently has a consensus price target of €65.75, suggesting a potential upside of 120.64%. Deutsche Beteiligungs has a consensus price target of €44.12, suggesting a potential upside of 13.56%. Given Grenke's higher probable upside, equities research analysts plainly believe Grenke is more favorable than Deutsche Beteiligungs.

Dividends

Grenke pays an annual dividend of €0.80 per share and has a dividend yield of 2.7%. Deutsche Beteiligungs pays an annual dividend of €0.80 per share and has a dividend yield of 2.1%. Grenke pays out 42.8% of its earnings in the form of a dividend. Deutsche Beteiligungs pays out 135.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Grenke is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Grenke beats Deutsche Beteiligungs on 6 of the 10 factors compared between the two stocks.

Ackermans & Van Haaren (EBR:ACKB) and Grenke (ETR:GLJ) are both financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Ackermans & Van Haaren and Grenke, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ackermans & Van Haaren0000N/A
Grenke13402.38

Grenke has a consensus target price of €65.75, suggesting a potential upside of 120.64%.

Earnings and Valuation

This table compares Ackermans & Van Haaren and Grenke's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ackermans & Van HaarenN/AN/AN/AN/AN/A
Grenke$537.48 million2.58$86.81 million€1.8715.96

Grenke has higher revenue and earnings than Ackermans & Van Haaren.

Profitability

This table compares Ackermans & Van Haaren and Grenke's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ackermans & Van HaarenN/AN/AN/A
GrenkeN/AN/AN/A

Summary

Grenke beats Ackermans & Van Haaren on 2 of the 2 factors compared between the two stocks.

Grenke (ETR:GLJ) and BlackRock Health Sciences Trust (BME:BME) are both financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, earnings, analyst recommendations and dividends.

Profitability

This table compares Grenke and BlackRock Health Sciences Trust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
GrenkeN/AN/AN/A
BlackRock Health Sciences TrustN/AN/AN/A

Earnings and Valuation

This table compares Grenke and BlackRock Health Sciences Trust's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Grenke$537.48 million2.58$86.81 million€1.8715.96
BlackRock Health Sciences TrustN/AN/AN/AN/AN/A

Grenke has higher revenue and earnings than BlackRock Health Sciences Trust.

Analyst Recommendations

This is a summary of recent ratings and price targets for Grenke and BlackRock Health Sciences Trust, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Grenke13402.38
BlackRock Health Sciences Trust0000N/A

Grenke presently has a consensus price target of €65.75, indicating a potential upside of 120.64%.

Summary

Grenke beats BlackRock Health Sciences Trust on 2 of the 2 factors compared between the two stocks.

BlackRock Income Trust (BME:BKT) and Grenke (ETR:GLJ) are both financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, valuation and profitability.

Earnings & Valuation

This table compares BlackRock Income Trust and Grenke's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BlackRock Income TrustN/AN/AN/AN/AN/A
Grenke$537.48 million2.58$86.81 million€1.8715.96

Grenke has higher revenue and earnings than BlackRock Income Trust.

Analyst Ratings

This is a summary of recent ratings and recommmendations for BlackRock Income Trust and Grenke, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BlackRock Income Trust0000N/A
Grenke13402.38

Grenke has a consensus price target of €65.75, indicating a potential upside of 120.64%.

Profitability

This table compares BlackRock Income Trust and Grenke's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BlackRock Income TrustN/AN/AN/A
GrenkeN/AN/AN/A

Summary

Grenke beats BlackRock Income Trust on 2 of the 2 factors compared between the two stocks.


Grenke Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
DWS Group GmbH & Co. KGaA (DWS.F) logo
DWS
DWS Group GmbH & Co. KGaA (DWS.F)
2.2$34.56+0.1%$6.91 billion$3.40 billion12.02High Trading Volume
MLP logo
MLP
MLP
1.5$6.27+1.1%$685.42 million$735.06 million16.85Upcoming Earnings
News Coverage
Deutsche Beteiligungs logo
DBAN
Deutsche Beteiligungs
1.5$38.85+1.0%$584.46 million$39.80 million65.85
ACKB
Ackermans & Van Haaren
0.5N/AN/A$0.00N/A0.00Gap Down
BlackRock Health Sciences Trust logo
BME
BlackRock Health Sciences Trust
0.5N/AN/A$0.00N/A0.00
BlackRock Income Trust logo
BKT
BlackRock Income Trust
0.4N/AN/A$0.00N/A0.00
BNY Mellon Strategic Municipal Bond Fund logo
DSM
BNY Mellon Strategic Municipal Bond Fund
0.6N/AN/A$0.00N/A0.00
Groupe Bruxelles Lambert SA (GBLB.BR) logo
GBLB
Groupe Bruxelles Lambert SA (GBLB.BR)
0.7N/AN/A$0.00N/A0.00
Rand Capital logo
RAND
Rand Capital
0.4N/AN/A$0.00N/A0.00News Coverage
PYX
Schroders plc (PYX.F)
0.5N/AN/A$0.00N/A0.00High Trading Volume
This page was last updated on 2/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.